Richard Grant to Angiotensin-Converting Enzyme Inhibitors
This is a "connection" page, showing publications Richard Grant has written about Angiotensin-Converting Enzyme Inhibitors.
Connection Strength
0.733
-
Continuation of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in the Face of Kidney Disease Progression-Safe and Possibly Life Saving. JAMA Intern Med. 2020 05 01; 180(5):727.
Score: 0.672
-
Management of the metabolic syndrome. Panminerva Med. 2005 Dec; 47(4):219-28.
Score: 0.062